Well this was my second meeting with Dr. Crisler... My inital meet we went over labs that I had done very recently but was not through labcorp. To save $$$ they allowed these labs to get me started off.. Unfortunately it did not show the E test he wanted but did show E was elevated.. He wasn't comfortable addressing E at this time and instead broke my test cyp pins to 2 x week and started me on 100iu of HCG daily. I did complain of low libido and water retention in the inital meet so he said he wanted to see how my body reacted to the changes he made with my protocol. So round 2 he got to see how E responded in the test that he wanted so based on that he made the decision to start me on this dose of AI. I did get confirmation from
Defy that .5mg is the correct dose he has ordered so I'm going to go with it...
I've suspected issues with E about 3 months after starting TRT 3 years ago with my primary care doc. Neither he or my Endo would consider looking into this possible issue... 3 years later it's being addressed by one of the top docs in the field... I'm going to gladly run with the protocol he's setup and not question it... If my E tanks then at least I'll pass the sweet spot and know what to look for and possibly see the other side.. I'm not to worried.. This has been a long time coming and I welcome the change...
Also here are my latest labs -
CBC With Differential/Platelet
WBC 5.5 x10E3/uL 3.4 - 10.8 01
RBC 5.23 x10E6/uL 4.14 - 5.80 01
Hemoglobin 16.5 g/dL 12.6 - 17.7 01
Hematocrit 48.7 % 37.5 - 51.0 01
MCV 93 fL 79 - 97 01
MCH 31.5 pg 26.6 - 33.0 01
MCHC 33.9 g/dL 31.5 - 35.7 01
RDW 14.0 % 12.3 - 15.4 01
Platelets 195 x10E3/uL 150 - 379 01
Neutrophils 53 % 01
Lymphs 35 % 01
Monocytes 9 % 01
Eos 2 % 01
Basos 1 % 01
Neutrophils (Absolute) 3.0 x10E3/uL 1.4 - 7.0 01
Lymphs (Absolute) 1.9 x10E3/uL 0.7 - 3.1 01
Monocytes(Absolute) 0.5 x10E3/uL 0.1 - 0.9 01
Eos (Absolute) 0.1 x10E3/uL 0.0 - 0.4 01
Baso (Absolute) 0.0 x10E3/uL 0.0 - 0.2 01
Immature Granulocytes 0 % 01
Immature Grans (Abs) 0.0 x10E3/uL 0.0 - 0.1 01
Comp. Metabolic Panel (14)
Glucose, Serum 72 mg/dL 65 - 99 01
BUN 19 mg/dL 6 - 24 01
Creatinine, Serum 1.22 mg/dL 0.76 - 1.27 01
eGFR If NonAfricn Am 74 mL/min/1.73 >59
eGFR If Africn Am 85 mL/min/1.73 >59
BUN/Creatinine Ratio 16 9 - 20
Sodium, Serum 138 mmol/L 134 - 144 01
Potassium, Serum 4.4 mmol/L 3.5 - 5.2 01
Chloride, Serum 98 mmol/L 97 - 108 01
Carbon Dioxide, Total 23 mmol/L 18 - 29 01
Calcium, Serum 9.2 mg/dL 8.7 - 10.2 01
Protein, Total, Serum 6.7 g/dL 6.0 - 8.5 01
Albumin, Serum 4.5 g/dL 3.5 - 5.5 01
Globulin, Total 2.2 g/dL 1.5 - 4.5
A/G Ratio 2.0 1.1 - 2.5
Bilirubin, Total 0.6 mg/dL 0.0 - 1.2 01
Alkaline Phosphatase, S 42 IU/L 39 - 117 01
AST (SGOT) 29 IU/L 0 - 40 01
ALT (SGPT) 35 IU/L 0 - 44 01
Testosterone,Free and Total
Testosterone, Serum 851 ng/dL 348 - 1197 01
Comment:
Adult male reference interval is based on a population of lean males
up to 40 years old.
Free Testosterone(Direct) 22.2 High pg/mL 6.8 - 21.5 02
DHEA-Sulfate 421.0 High ug/dL 102.6 - 416.3 01
TSH 1.040 uIU/mL 0.450 - 4.500 01
Prostate-Specific Ag, Serum
Prostate Specific Ag, Serum 0.7 ng/mL 0.0 - 4.0 01
Roche ECLIA methodology.
According to the American Urological Association, Serum PSA should
decrease and remain at undetectable levels after radical
prostatectomy. The AUA defines biochemical recurrence as an initial
PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory
PSA value 0.2 ng/mL or greater.
Values obtained with different assay methods or kits cannot be used
interchangeably. Results cannot be interpreted as absolute evidence
of the presence or absence of malignant disease.
Estradiol, Sensitive 56.2 High pg/mL 8.0 - 35.0 02
This test was developed and its performance characteristics
determined by LabCorp. It has not been cleared by the Food and
Drug Administration.
Methodology: Liquid chromatography tandem mass spectrometry(LC/MS/MS)
Triiodothyronine,Free,Serum 2.9 pg/mL 2.0 - 4.4 01
